European Association of Dermato-Oncology 14th European Post-Chicago Melanoma Skin Cancer Meeting 2024

European Association of Dermato-Oncology 14th European Post-Chicago Melanoma Skin Cancer Meeting 2024

Include: 26 videos + 1 pdf, size: 21.1 GB

 Target Audience: dermatologists, oncologists, pathologists

 Information:

The 14th European Post-Chicago Melanoma Skin Cancer Meeting 2024 is designed for medical professionals specializing in melanoma and skin cancer treatment. The target audience includes:

• Dermatologists and oncologists focused on melanoma and skin cancer.
• Clinical researchers involved in melanoma diagnostics and therapy.
• Pathologists specializing in skin cancer histopathology.
• Medical professionals interested in immuno-oncology and targeted therapies.
• Industry experts working on drug development and clinical trials.

This interdisciplinary conference provides a comprehensive overview of the latest advancements in melanoma diagnostics, treatment strategies, and emerging therapies. It fosters direct communication between clinicians, researchers, and industry representatives

Topics:

• 16_EPCM-2024_FINAL-Program_web.pdf
• CLOSING REMARKS.mp4
• KEYNOTE LECTURE I.mp4
• KEYNOTE LECTURE II.mp4
• KEYNOTE LECTURE III.mp4
• KEYNOTE LECTURE IV.mp4
• OPENING OF THE CONFERENCE.mp4
• PARALLEL SYMPOSIUM I Adverse event management of targeted and immunotherapies.mp4
• PARALLEL SYMPOSIUM II Real world evidence studies from registries.mp4
• PARALLEL SYMPOSIUM III Cutaneous T-cell lymphoma (CTCL).mp4
• PARALLEL SYMPOSIUM IV Interactive Discussion of complex melanoma cases.mp4
• PARALLEL SYMPOSIUM V Interactive Discussion of complex non-melanoma cases.mp4
• PARALLEL SYMPOSIUM VI Innovative therapies for orphan diseases.mp4
• SATELLITE SYMPOSIUM I NOVARTIS Gold Sponsor Yesterday, Today & Tomorrow Long-Term Benefits with Targeted Therapy in Adjuvant Melanoma.mp4
• SATELLITE SYMPOSIUM II BMS Gold Sponsor IO-Combinations in Melanoma- How to Proceed – Less or More.mp4
• SATELLITE SYMPOSIUM III MSD Platinum Sponsor Advancements in Early Melanoma Integrating Recent Updates into Clinical Practice.mp4
• SATELLITE SYMPOSIUM V REGENERON Platinum Sponsor Evolving Perspectives on Treatment Roadmap for Advanced Non-melanoma Skin Cancer.mp4
• SATELLITE SYMPOSIUM VI PHILOGEN Sponsor Novel treatments for locally advanced skin cancers.mp4
• SATELLITE SYMPOSIUM VII MERCK Bronze Sponsor Leveraging Real-World Evidence in Advanced Merkel Cell Carcinoma- Insights from Clinical Practice.mp4
• SYMPOSIUM I My personal highlights at ASCO 2024.mp4
• SYMPOSIUM II Which vaccines work and which not.mp4
• SYMPOSIUM III The role of gut microbiome for immunooncology.mp4
• SYMPOSIUM IV Bispecific T-cell engagers (BTE) in cutaneous and uveal melanomas (unrestricted Educational Grant Immunocore).mp4
• SYMPOSIUM V Controversy- Is neoadjuvant or perioperative ICI already standard of care.mp4
• SYMPOSIUM VI Adjuvant treatment of melanoma.mp4
• SYMPOSIUM VII Intralesional therapies for melanoma and NMSC.mp4
• SYMPOSIUM VIII What’s new in NMSC Publication highlights from the last 12 months.mp4